62281-05-4

Basic information

• Product Name: 2-Hexyldecan-1-amine
• Synonyms: 2-Hexyldecan-1-amine;2-Hexyl-2-octyl-aethyl-amin;1-Decanamine, 2-hexyl-;2-Hexyldecylamine
• CAS NO: 62281-05-4
• Molecular Formula: C16H35N
• Molecular Weight: 241.4558
• Mol File: 62281-05-4.mol
• Article Data: 8

Chemical Properties

• Boiling Point: 150°C/15mmHg(lit.)
• Appearance: /
• Density: 0.813±0.06 g/cm3(Predicted)
• Refractive Index: 1.4470 to 1.4510
• PKA: 10.80±0.10(Predicted)
• CAS DataBase Reference: 2-Hexyldecan-1-amine(CAS DataBase Reference)
• NIST Chemistry Reference: 2-Hexyldecan-1-amine(62281-05-4)
• EPA Substance Registry System: 2-Hexyldecan-1-amine(62281-05-4)

Safety Data

• Hazardous Substances Data: 62281-05-4(Hazardous Substances Data)

Usage

Uses

2-Hexyldecan-1-amine is a reagent for the synthesis of triphenylene 2,3-dicarboxylic imides as luminescent liquid crystals, and the study of their optical and electronic properties.

Upstream product

• 111-25-1 1-bromo-hexane 
• 74918-57-3 2-hexyldecanoic acid chloride 
• 25354-97-6 2-hexyldecanoic acid 
• 1608483-87-9 2-hexyldecanoyl amide 
• 52997-43-0 7-(bromomethyl)pentadecane 
• 2425-77-6 2-hexyldecan-1-ol 
• 1355961-63-5 2-(pentadecan-7-ylmethyl)isoindole-1,3-dione 

Relevant articles and documents

Synthesis and properties of small band gap thienoisoindigo based conjugated polymers

Using Stille and Suzuki polymerization reactions we incorporate thienoisoindigo (TII) as an acceptor co-monomer into a series of alternating π-conjugated copolymers with combinations of benzene, thiophene and carbazole as donor co-monomers. By changing the nature and length of the donor segments, the optical band gap of these soluble TII copolymers can be varied over a large range from 1.52 eV down to 0.87 eV. The semiconducting properties of the TII copolymers were established in bottom-gate bottom-contact field-effect transistors that provide hole mobilities for these materials in the range of 10-3 to 10-2 cm2 V-1 s-1.

LIPID DELIVERY OF THERAPEUTIC AGENTS TO ADIPOSE TISSUE

A method of treating a disease mediated by protein expression in adipose tissue by intraperitoneally administering a composition comprising a lipid nanoparticle encapsulating or associated with a therapeutic agent (e.g., a nucleic acid), thereby delivering the therapeutic agent to adipose tissue of the subject and altering protein expression in the adipose tissue is provided herein. A method for delivering a therapeutic agent to adipose tissue of a subject in need thereof is also provided.

Thieno[3,4-c]pyrrole-4,6-dione-3,4-difluorothiophene Polymer Acceptors for Efficient All-Polymer Bulk Heterojunction Solar Cells

Branched-alkyl-substituted poly(thieno[3,4-c]pyrrole-4,6-dione-alt-3,4-difluorothiophene) (PTPD[2F]T) can be used as a polymer acceptor in bulk heterojunction (BHJ) solar cells with a low-band-gap polymer donor (PCE10) commonly used with fullerenes. The “all-polymer” BHJ devices made with PTPD[2F]T achieve efficiencies of up to 4.4 %. While, to date, most efficient polymer acceptors are based on perylenediimide or naphthalenediimide motifs, our study of PTPD[2F]T polymers shows that linear, all-thiophene systems with adequately substituted main chains can also be conducive to efficient BHJ solar cells with polymer donors.